24 HR empagliflozin 10 MG / linagliptin 5 MG / metformin hydrochloride 1000 MG 24HR Extended Release Oral Tablet

RxCUI: 2359279
RxNorm name: 24 HR empagliflozin 10 MG / linagliptin 5 MG / metformin hydrochloride 1000 MG 24HR Extended Release Oral Tablet
Display name: 24 HR empagliflozin 10 MG / linagliptin 5 MG / metformin hydrochloride 1000 MG 24HR Extended Release Oral Tablet
Full name: 24 HR empagliflozin 10 MG / linagliptin 5 MG / metformin hydrochloride 1000 MG 24HR Extended Release Oral Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Trijardy XR	EMPAGLIFLOZIN, LINAGLIPTIN, METFORMIN HYDROCHLORIDE	Boehringer Ingelheim Pharmaceuticals, Inc.	71873567-9594-452a-bb92-34a129adecac	2026-01-30	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2359279

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
71873567-9594-452a-bb92-34a129adecac	24 HR empagliflozin 10 MG / linagliptin 5 MG / metformin hydrochloride 1000 MG 24HR Extended Release Oral Tablet	SY	10	These highlights do not include all the information needed to use TRIJARDY XR safely and effectively. See full prescribing information for TRIJARDY XR. TRIJARDY ® XR (empagliflozin, linagliptin, and metformin hydrochloride extended-release tablets), for oral use Initial U.S. Approval: 2020	20260130
71873567-9594-452a-bb92-34a129adecac	24 HR empagliflozin 10 MG / linagliptin 5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet	SCD	10	These highlights do not include all the information needed to use TRIJARDY XR safely and effectively. See full prescribing information for TRIJARDY XR. TRIJARDY ® XR (empagliflozin, linagliptin, and metformin hydrochloride extended-release tablets), for oral use Initial U.S. Approval: 2020	20260130
71873567-9594-452a-bb92-34a129adecac	empagliflozin 10 MG / linagliptin 5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet	PSN	10	These highlights do not include all the information needed to use TRIJARDY XR safely and effectively. See full prescribing information for TRIJARDY XR. TRIJARDY ® XR (empagliflozin, linagliptin, and metformin hydrochloride extended-release tablets), for oral use Initial U.S. Approval: 2020	20260130